These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30 related articles for article (PubMed ID: 3658997)
1. The value of prognostic factors in prostatic cancer. Schubert J; Kowalik S Int Urol Nephrol; 1994; 26(5):541-7. PubMed ID: 7860202 [TBL] [Abstract][Full Text] [Related]
2. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer]. Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115 [No Abstract] [Full Text] [Related]
3. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate]. Habib FK; Chisholm GD Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672 [No Abstract] [Full Text] [Related]
4. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer. Nishiyama T; Hashimoto Y; Takahashi K Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082 [TBL] [Abstract][Full Text] [Related]
5. Punch biopsy tissue: enzyme and receptor analyses as criteria for hormone responsiveness in the treatment of prostatic cancer--limitations. Bartsch G; Janetschek G; Daxenbichler G; Dietze O; Mikuz G Prog Clin Biol Res; 1987; 243A():101-10. PubMed ID: 3658997 [No Abstract] [Full Text] [Related]
6. Uses and limitations of hormone, receptor and enzyme assays in prostate cancer. Martin PM; Le Goff JM; Brisset JM; Ojasoo T; Husson JM; Raynaud JP Prog Clin Biol Res; 1987; 243A():111-40. PubMed ID: 3309969 [No Abstract] [Full Text] [Related]
7. A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer. Barrack ER; Tindall DJ Prog Clin Biol Res; 1987; 239():155-87. PubMed ID: 3309954 [No Abstract] [Full Text] [Related]